ArticleMolecular diversity2024
Exploring host epigenetic enzymes as targeted therapies for visceral leishmaniasis: in silico design and in vitro efficacy of KDM6B and ASH1L inhibitors.
Mukul Dutta et al.PubMed ↗Publisher ↗
No numbers read from the abstract.